| mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-10 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-10 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
9e-10 |
| mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-09 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
9e-09 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-08 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-08 |
| mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-08 |
| mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-08 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-08 |